By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2910 Seventh Street

Berkeley  California  94710  U.S.A.
Phone: 510-204-7200 or 800-BIO-XOMA
Fax: 510-644-0539



Company News
Bay Area's XOMA (US) LLC (XOMA) Crashes on Disappointing Phase III Data 7/22/2015 6:22:39 AM
XOMA (US) LLC (XOMA) To Announce Second Quarter 2015 Financial Results And Host Webcast On August 6 7/17/2015 7:29:21 AM
XOMA (US) LLC (XOMA) Receives Orphan Drug Designation For XOMA 358 From FDA For Treatment Of Congenital Hyperinsulinism (HI) 6/16/2015 7:28:00 AM
XOMA (US) LLC (XOMA) Announces Phase III EYEGUARD-B Study Reaches Target Exacerbation Event 5/28/2015 6:56:59 AM
XOMA (US) LLC (XOMA) Reports First Quarter 2015 Achievements And Financial Results 5/8/2015 7:38:59 AM
XOMA (US) LLC (XOMA) To Present At Credit Suisse Antibody Day 2015 5/4/2015 3:03:05 PM
XOMA (US) LLC (XOMA) To Announce First Quarter 2015 Financial Results And Host Conference Call On May 7 4/30/2015 1:24:18 PM
XOMA (US) LLC (XOMA) Highlights Recent Achievements And Reports Fourth Quarter And Full-Year 2014 Financial Results 3/12/2015 7:41:26 AM
XOMA (US) LLC (XOMA) Presents Positive Phase I XOMA 358 Data At The ENDO Meeting 3/9/2015 7:28:45 AM
XOMA (US) LLC (XOMA) Will Present XOMA 358 Phase 1 Data At ENDO 2015 3/6/2015 7:28:57 AM